[go: up one dir, main page]

BR9810500A - System and apparatus for the transfer of nucleic acid in vivo into the cells of multicellular eukaryotic organisms - Google Patents

System and apparatus for the transfer of nucleic acid in vivo into the cells of multicellular eukaryotic organisms

Info

Publication number
BR9810500A
BR9810500A BR9810500-0A BR9810500A BR9810500A BR 9810500 A BR9810500 A BR 9810500A BR 9810500 A BR9810500 A BR 9810500A BR 9810500 A BR9810500 A BR 9810500A
Authority
BR
Brazil
Prior art keywords
cells
nucleic acid
vivo
transfer
devices
Prior art date
Application number
BR9810500-0A
Other languages
Portuguese (pt)
Inventor
Michel Bureau
Lluis Mir
Daniel Scherman
Bertrand Schwartz
Original Assignee
Rhone Poulenc Rorer Sa
Roussy Inst Gustave
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9708232A external-priority patent/FR2765241B1/en
Priority claimed from FR9708233A external-priority patent/FR2765242B1/en
Application filed by Rhone Poulenc Rorer Sa, Roussy Inst Gustave, Centre Nat Rech Scient filed Critical Rhone Poulenc Rorer Sa
Publication of BR9810500A publication Critical patent/BR9810500A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrotherapy Devices (AREA)

Abstract

"SISTEMA E APARELHO PARA A TRANSFERêNCIA DE áCIDO NUCLéICO IN VIVO PARA O INTERIOR DE CéLULAS DE ORGANISMOS EUCARIóTICOS PLURICELULARES". Esta invenção refere-se a sistemas e aparelhos que proporcionam um aumento notável da transferência, in vivo, para o interior de células, particularmente células de músculos e células de tumor, de vetores de ácidos nucléicos utilizando-se campos elétricos fracos, de modo a incrementar a eficiência desse tipo de transferências. Os aparelhos da invenção são projetados para proporcionar um gradiente de voltagem ótimo para incrementar a migração de vetores de ácido nucléico para o interior de células, sem danificar as células ou o tecido. Esses aparelhos caracterizam-se por disposições únicas de eletrodos, e por limites de potência únicos definidos por ajustes de voltagem máxima."SYSTEM AND APPARATUS FOR THE TRANSFER OF NUCLEIC ACID IN VIVO TO THE INTERIOR OF CELLS OF PLURICELLULAR EUCHARIOTIC ORGANISMS". This invention relates to systems and devices that provide a notable increase in the transfer, in vivo, into cells, particularly muscle cells and tumor cells, of nucleic acid vectors using weak electric fields in order to increase the efficiency of such transfers. The devices of the invention are designed to provide an optimal voltage gradient to increase the migration of nucleic acid vectors into cells, without damaging cells or tissue. These devices are characterized by unique electrode arrangements, and unique power limits defined by maximum voltage adjustments.

BR9810500-0A 1997-06-30 1998-06-30 System and apparatus for the transfer of nucleic acid in vivo into the cells of multicellular eukaryotic organisms BR9810500A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR9708232A FR2765241B1 (en) 1997-06-30 1997-06-30 IMPROVEMENT OF NUCLEIC ACID TRANSFER IN CELLS OF PLURICELLULAR EUKARYOTIC ORGANISMS AND COMBINATION FOR CARRYING OUT THE METHOD
FR9708233A FR2765242B1 (en) 1997-06-30 1997-06-30 IMPROVEMENT OF THE TRANSFER OF NUCLEIC ACID IN THE STRIKE MUSCLE AND COMBINATION ALLOWING THE IMPLEMENTATION OF THE PROCESS
US6748897P 1997-12-01 1997-12-01
US6748797P 1997-12-01 1997-12-01
US8385898P 1998-05-01 1998-05-01
PCT/EP1998/003976 WO1999001175A1 (en) 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Publications (1)

Publication Number Publication Date
BR9810500A true BR9810500A (en) 2000-09-05

Family

ID=27515625

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810500-0A BR9810500A (en) 1997-06-30 1998-06-30 System and apparatus for the transfer of nucleic acid in vivo into the cells of multicellular eukaryotic organisms

Country Status (11)

Country Link
EP (1) EP0993318A1 (en)
JP (1) JP2002515816A (en)
KR (1) KR20010014298A (en)
CN (1) CN1261812A (en)
AU (1) AU8730798A (en)
BR (1) BR9810500A (en)
CA (1) CA2295029A1 (en)
IL (1) IL133709A0 (en)
NO (1) NO996540L (en)
PL (1) PL337617A1 (en)
WO (1) WO1999001175A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753379B1 (en) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa METHOD OF TREATING AMYOTROPHIC SIDE SCLEROSIS
US6261281B1 (en) * 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
EP1148885A4 (en) * 1999-02-08 2002-05-08 Chiron Corp Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
CA2402530C (en) 2000-03-13 2014-01-14 Cornell Research Foundation, Inc. Blocking leukocyte emigration and inflammation by interfering with cd99
AU5345901A (en) 2000-04-13 2001-10-30 Univ Rockefeller Enhancement of antibody-mediated immune responses
EP1292359A4 (en) 2000-05-22 2005-03-30 Merck & Co Inc SYSTEM AND METHOD FOR EVALUATING THE EFFECTIVENESS OF A PHARMACEUTICAL ACID DELIVERY SYSTEM
MXPA03005386A (en) 2000-12-28 2004-04-20 Wyeth Corp Recombinant protective protein from $i(streptococcus pneumoniae).
CA2441476A1 (en) 2001-03-02 2002-09-12 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
US20020198567A1 (en) * 2001-06-07 2002-12-26 Yona Keisari Electro-endocytotic therapy as a treatment modality of cancer
MX339524B (en) 2001-10-11 2016-05-30 Wyeth Corp NEW IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCICAL DISEASE.
US20050154434A1 (en) 2002-03-07 2005-07-14 Adam Simon Clinical syringe with electrical stimulation aspects
EP2316922B1 (en) 2002-05-24 2013-05-22 Merck Sharp & Dohme Corp. Neutralizing human anti-IGFR antibody
US7785608B2 (en) 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
EP1759714A1 (en) * 2005-09-02 2007-03-07 Bioalliance Pharma Electrotransfer of nucleic acid into tissue cells
WO2007039799A2 (en) * 2005-10-03 2007-04-12 Novocure Ltd. Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
JP4961137B2 (en) * 2005-12-14 2012-06-27 久光製薬株式会社 Device for iontophoresis
PL2068922T3 (en) 2006-10-19 2012-11-30 Csl Ltd Anti-il-13r alpha 1 antibodies and their uses thereof
PL2068921T3 (en) 2006-10-19 2014-12-31 Csl Ltd High affinity antibody antagonists of interleukin-13 receptor alpha 1
AR064642A1 (en) 2006-12-22 2009-04-15 Wyeth Corp POLINUCLEOTIDE VECTOR THAT INCLUDES IT RECOMBINATING CELL THAT UNDERSTANDS THE VECTOR POLYPEPTIDE, ANTIBODY, COMPOSITION THAT UNDERSTANDS THE POLINUCLEOTIDE, VECTOR, RECOMBINATING CELL POLYPEPTIDE OR ANTIBODY, USE OF THE COMPOSITION AND A COMPOSITION AND A METHOD
US8246176B2 (en) 2007-03-06 2012-08-21 Sanyo Electric Co., Ltd. Projection display device having an operation section for displacing a lens
US8093043B2 (en) 2008-06-04 2012-01-10 New York University β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
DK2310500T3 (en) * 2008-07-18 2015-05-11 Maxcyte Inc Process for optimizing electroporation
MX2011004755A (en) 2008-11-05 2011-10-10 Wyeth Llc Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease.
PT3246044T (en) 2010-08-23 2021-02-15 Wyeth Llc Stable formulations of neisseria meningitidis rlp2086 antigens
AU2011300409B2 (en) 2010-09-10 2015-03-26 Wyeth Llc Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
SA115360586B1 (en) 2012-03-09 2017-04-12 فايزر انك Neisseria meningitidis compositions and methods thereof
US8986710B2 (en) 2012-03-09 2015-03-24 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
WO2014107739A1 (en) 2013-01-07 2014-07-10 Eleven Biotherapeutics, Inc. Antibodies against pcsk9
WO2014136064A2 (en) 2013-03-08 2014-09-12 Pfizer Inc. Immunogenic fusion polypeptides
MX369534B (en) 2013-09-08 2019-11-11 Pfizer Neisseria meningitidis compositions and methods thereof.
RU2723045C2 (en) 2015-02-19 2020-06-08 Пфайзер Инк. Compositions of neisseria meningitidis and methods for preparation thereof
SG10202111092UA (en) 2017-01-31 2021-11-29 Pfizer Neisseria meningitidis compositions and methods thereof
CN110527625A (en) * 2018-05-24 2019-12-03 苏州壹达生物科技有限公司 A kind of streaming electrotransfection device of combination high pressure and low-voltage
CA3155669A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9317380D0 (en) * 1993-08-20 1993-10-06 Therexsys Ltd Transfection process
US5641680A (en) * 1994-11-14 1997-06-24 Zhao; Xi Gene transfer apparatus and method for using the same
WO1997007826A1 (en) * 1995-08-29 1997-03-06 Cbr Laboratories, Inc. In vivo electroporation of cells

Also Published As

Publication number Publication date
NO996540L (en) 2000-02-03
WO1999001175A1 (en) 1999-01-14
IL133709A0 (en) 2001-04-30
CN1261812A (en) 2000-08-02
PL337617A1 (en) 2000-08-28
KR20010014298A (en) 2001-02-26
EP0993318A1 (en) 2000-04-19
NO996540D0 (en) 1999-12-29
JP2002515816A (en) 2002-05-28
AU8730798A (en) 1999-01-25
CA2295029A1 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
BR9810500A (en) System and apparatus for the transfer of nucleic acid in vivo into the cells of multicellular eukaryotic organisms
NO996541L (en) Improved method of transferring nucleic acid to cells in multicellular, eukaryotic organism combined with this
BR9912587A (en) System and device process for enhancing cellular absorption of a substance, processes for enhancing gene transfection of a gene transferred to a target region of a patient's body and to promote angiogenesis in ischemic limbs, and, kit
BR9606502A (en) Power transmission system for high voltage direct current
EP0892644A4 (en) IN VIVO GENE TRANSFER METHOD FOR WOUND HEALING
BR9810369A (en) Process of transferring nucleic acid into one or more striated muscles, in vivo, composition, mucleic acid and electric field, and, combination product
BR9809016A (en) Ground feeding device for electric vehicle
NO20011690L (en) Electric energy transfer system
BR0209989A (en) Chromosome-based platforms
BRPI0512607A (en) device for transferring molecules to cells that uses an electric force
BR0115701A (en) Power supply
BR0303573A (en) Automatic or semi-automatic external defibrillator, automatic or semi-automatic external defibrillator system, power supply for an automatic or semi-automatic external defibrillator, and method
MX152447A (en) IMPROVEMENTS IN THE ELECTRICAL ENERGY CONTROL SYSTEM TO SUPPLY LOADS AS FLUORESCENT, INCANDESCENT OR SIMILAR LIGHTING
BR9801936C1 (en) Transmission duct apparatus and installation method
DE59712359D1 (en) Arrangement for the supply of electrical energy
DE59912054D1 (en) Device for the supply of electrical energy
ITPC970039A0 (en) FLEXIBLE SYSTEM FOR THE DISTRIBUTION OF ENERGY AND ELECTRICAL SIGNALS
DE69839411D1 (en) System for electric power transmission, with DC voltage regulation
AU3698297A (en) Compositions containing at least one nucleic acid and their applications in the biomedical field, particularly in gene therapy
IT1268536B1 (en) PERFECTED DEVICE FOR THE ENERGY MANAGEMENT OF ELECTRICAL LOADS
DE69824346D1 (en) Process for controlling the power of electric arc furnaces
IT1309204B1 (en) TERMINALS FOR THE CONNECTION OF CABLES, ELECTRIC AND NON-ELECTRIC POWER CONDUCTORS.
AU1029099A (en) Transfection system for the transfer of nucleic acids into cells
DE69835733D1 (en) Electric power distribution system
HUP0100660A1 (en) Use of negative regulation elements for nerve-specific expression of transgenes

Legal Events

Date Code Title Description
TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1889 DE 20/03/2007.